Vivani Medical Stock Today
| VANI Stock | USD 1.45 0.01 0.69% |
Performance7 of 100
| Odds Of DistressOver 73
|
Vivani Medical is trading at 1.45 as of the 29th of November 2024. This is a 0.69% up since the beginning of the trading day. The stock's open price was 1.44. Vivani Medical has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Vivani Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of December 2022 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of November 2014 | Category Healthcare | Classification Health Care |
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company has 59.23 M outstanding shares of which 531.02 K shares are at this time shorted by private and institutional investors with about 12.59 trading days to cover. More on Vivani Medical
Moving together with Vivani Stock
Moving against Vivani Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Vivani Stock Highlights
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Medical Equipment, Health Care, Biotechnology, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vivani Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Vivani Medical's financial leverage. It provides some insight into what part of Vivani Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vivani Medical (VANI) is traded on NASDAQ Exchange in USA. It is located in 1350 South Loop Road, Alameda, CA, United States, 94502 and employs 36 people. Vivani Medical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.89 M. Vivani Medical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 59.23 M outstanding shares of which 531.02 K shares are at this time shorted by private and institutional investors with about 12.59 trading days to cover.
Vivani Medical currently holds about 3.45 M in cash with (23.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check Vivani Medical Probability Of Bankruptcy
Ownership AllocationVivani Medical shows a total of 59.23 Million outstanding shares. Vivani Medical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Vivani Ownership Details
Vivani Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 30 K | |
| Two Sigma Securities, Llc | 2024-06-30 | 25.7 K | |
| Group One Trading, Lp | 2024-06-30 | 14.4 K | |
| Tower Research Capital Llc | 2024-06-30 | 13.4 K | |
| Susquehanna International Group, Llp | 2024-06-30 | 10.3 K | |
| Goss Wealth Management Llc | 2024-06-30 | 1.4 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.1 K | |
| Royal Bank Of Canada | 2024-06-30 | 490 | |
| Qube Research & Technologies | 2024-06-30 | 402 | |
| Sabby Management Llc | 2024-06-30 | 2.1 M | |
| Tanager Wealth Management Llp | 2024-09-30 | 1.3 M |
Vivani Medical Historical Income Statement
Vivani Stock Against Markets
Vivani Medical Corporate Management
| Brigid Makes | Chief Officer | Profile | |
| Adam Mendelsohn | Chairman CoFounder | Profile | |
| Truc MBA | Chief Officer | Profile | |
| Donald MBA | Chief Secretary | Profile | |
| Lisa MD | Chief Officer | Profile | |
| Kayte Fischer | CoFounder | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.43) | Return On Assets (0.29) | Return On Equity (0.86) |
The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.